Pfizer Stock Soars 12% on Strong Q4 2025 Earnings; Net Profit Jumps 85%, Dividend Declared; Get Payout Details

Shares of Pfizer Ltd witnessed robust buying interest on Tuesday, rallying by as much as 11.99% to touch an intraday high of Rs 4,970.40 on the Bombay Stock Exchange (BSE). The surge followed the company's announcement of a strong financial performance for the fourth quarter ended March 2025.

Pfizer Share Price Today: Current Stock Movements of Pfizer

On Tuesday, the shares of Pfizer Limited closed at Rs 4,890.00, rising Rs 422.00 or 9.44% from the previous close of Rs 4,468.00. The stock opened at Rs 4,575.00, touched an intraday high of Rs 5,050.00, and a low of Rs 4,575.00 during the session. Pfizer's share is currently trading well above its recent 52-week low of Rs 3,701.00, but still below its 52-week high of Rs 6,451.15.

The Volume Weighted Average Price (VWAP) stood at Rs 4,953.48. The daily volatility was measured at 1.59%, while annualised volatility stood at 30.38%. The stock moved within a 20% price band, with the upper circuit at Rs 5,361.60 and the lower circuit at Rs 3,574.40.

Pfizer Q4 Results 2025 Highlights

In its Q4 FY25 results, Pfizer reported an impressive 85% year-on-year (YoY) growth in net profit, which rose to Rs 331 crore compared to Rs 179 crore in the same quarter last year. Revenue from operations also increased by 8.3% YoY, reaching Rs 591.9 crore, up from Rs 546.6 crore a year earlier.

On the operational front, earnings before interest, tax, depreciation and amortisation (EBITDA) saw a healthy rise of 20.1%, coming in at Rs 227.5 crore for the March quarter, up from Rs 189.43 crore in Q4 FY24. The EBITDA margin expanded to 38.4%, reflecting strong cost control and efficiency gains, compared to 34.7% in the same period last year.

Pfizer Announced Dividend for FY 2025: Check Recording Date, Payout Details

Pfizer also announced a hefty total dividend of Rs 165 per equity share for FY25. This includes a final dividend of Rs 35 per share (350%), a special dividend of Rs 100 per share (1,000%) to mark the company's 75th year in India, and an additional Rs 30 per share (300%) as a special dividend linked to the gain on transfer of leasehold land and building. The record date for dividend entitlement has been fixed as 9 July 2025.

About Pfizer

Pfizer, headquartered in New York City, is one of the world's leading biopharmaceutical companies, with a presence in over 125 countries. It focuses on innovative medicines and vaccines across therapeutic areas such as oncology, vaccines, internal medicine, and rare diseases. The company played a pivotal role during the pandemic through its mRNA-based COVID-19 vaccine.

In India, Pfizer has a significant presence with a modern manufacturing facility in Goa, supporting both domestic distribution and global supply chains. The company also offers a wide range of well-known over-the-counter health products, including Centrum, Advil, Nexium, and ChapStick.